Universal Beteiligungs und Servicegesellschaft mbH Acquires New Shares in The Cigna Group (NYSE:CI)

Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in The Cigna Group (NYSE:CI - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 280,612 shares of the health services provider's stock, valued at approximately $77,488,000. Universal Beteiligungs und Servicegesellschaft mbH owned about 0.10% of The Cigna Group at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Two Sigma Investments LP lifted its holdings in shares of The Cigna Group by 32.6% during the fourth quarter. Two Sigma Investments LP now owns 764,900 shares of the health services provider's stock valued at $211,219,000 after acquiring an additional 188,235 shares during the period. Deroy & Devereaux Private Investment Counsel Inc. lifted its position in shares of The Cigna Group by 1.1% during the fourth quarter. Deroy & Devereaux Private Investment Counsel Inc. now owns 75,837 shares of the health services provider's stock worth $20,942,000 after purchasing an additional 858 shares in the last quarter. Valley Wealth Managers Inc. grew its stake in shares of The Cigna Group by 2.8% during the fourth quarter. Valley Wealth Managers Inc. now owns 56,933 shares of the health services provider's stock valued at $15,721,000 after purchasing an additional 1,548 shares during the last quarter. Humankind Investments LLC increased its holdings in shares of The Cigna Group by 12.1% in the fourth quarter. Humankind Investments LLC now owns 5,294 shares of the health services provider's stock valued at $1,462,000 after purchasing an additional 571 shares in the last quarter. Finally, KBC Group NV raised its holdings in The Cigna Group by 1.5% during the 4th quarter. KBC Group NV now owns 550,638 shares of the health services provider's stock worth $152,053,000 after purchasing an additional 8,077 shares during the last quarter. Institutional investors and hedge funds own 86.99% of the company's stock.

The Cigna Group Trading Up 0.3%

Shares of The Cigna Group stock traded up $0.97 during trading hours on Thursday, hitting $311.83. The company's stock had a trading volume of 1,745,696 shares, compared to its average volume of 1,714,806. The firm has a fifty day moving average of $325.02 and a 200-day moving average of $309.96. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.72 and a current ratio of 0.66. The Cigna Group has a twelve month low of $262.03 and a twelve month high of $370.83. The stock has a market cap of $83.30 billion, a price-to-earnings ratio of 25.48, a P/E/G ratio of 0.98 and a beta of 0.47.

The Cigna Group (NYSE:CI - Get Free Report) last issued its earnings results on Friday, May 2nd. The health services provider reported $6.74 earnings per share for the quarter, topping the consensus estimate of $6.35 by $0.39. The company had revenue of $65.45 billion for the quarter, compared to analyst estimates of $60.39 billion. The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. The firm's revenue for the quarter was up 14.4% compared to the same quarter last year. During the same period in the prior year, the business posted $6.47 earnings per share. Research analysts forecast that The Cigna Group will post 29.77 EPS for the current year.

The Cigna Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, June 18th. Shareholders of record on Tuesday, June 3rd will be given a $1.51 dividend. This represents a $6.04 annualized dividend and a yield of 1.94%. The ex-dividend date is Tuesday, June 3rd. The Cigna Group's dividend payout ratio is 33.44%.

Insider Activity

In other news, Director Elder Granger sold 2,376 shares of the firm's stock in a transaction on Friday, March 14th. The shares were sold at an average price of $310.35, for a total transaction of $737,391.60. Following the completion of the transaction, the director now owns 5,471 shares of the company's stock, valued at approximately $1,697,924.85. This trade represents a 30.28% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO David Cordani sold 26,527 shares of the firm's stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $308.12, for a total transaction of $8,173,499.24. Following the completion of the sale, the chief executive officer now owns 127,767 shares of the company's stock, valued at $39,367,568.04. The trade was a 17.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 43,751 shares of company stock valued at $13,603,991. 0.70% of the stock is owned by insiders.

Analyst Ratings Changes

CI has been the subject of a number of recent research reports. Royal Bank of Canada set a $355.00 price target on The Cigna Group in a research report on Friday, January 31st. Morgan Stanley raised their price target on shares of The Cigna Group from $379.00 to $390.00 and gave the stock an "overweight" rating in a report on Monday, May 5th. Truist Financial boosted their price objective on The Cigna Group from $385.00 to $405.00 and gave the stock a "buy" rating in a research report on Monday, May 12th. Wells Fargo & Company decreased their target price on The Cigna Group from $370.00 to $341.00 and set an "equal weight" rating on the stock in a research note on Tuesday, February 4th. Finally, Cowen reiterated a "buy" rating on shares of The Cigna Group in a research report on Monday, May 5th. Two investment analysts have rated the stock with a hold rating, sixteen have given a buy rating and three have assigned a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Buy" and an average price target of $379.33.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.